Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

High BMI and waist circumference associated with increased risk of aggressive prostate cancer

Research

A study of almost 150,000 men from 8 European countries, presented at this year’s European Obesity Summit (Gothenburg, 1-4 June) shows that higher body mass index (BMI) and waist circumference are associated with an increased risk of aggressive prostate cancer.

© kwanchai.c - Shutterstock

Image courtesy of Shutterstock

This analysis of the European Prospective Investigation into Cancer and Nutrition (EPIC) is by Dr Aurora Pérez-Cornago, Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, UK, and colleagues.

To date, evidence on the association of body size and adiposity with prostate cancer risk is not clear. In this study, the authors investigated the associations between various body measurements at baseline, mainly BMI and waist circumference, and the risk of prostate cancer incidence, with a focus on tumour stage and grade, and on mortality from prostate cancer. A total of 141,896 men in 8 European countries (Italy, Spain, United Kingdom, the Netherlands, Greece, Germany, Sweden, and Denmark) from the EPIC cohort were included. Data were adjusted for education level, smoking, marital status, diabetes and physical activity.

Read more (Nuffield Department of Population Health)

Similar stories

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

Tinnitus seems linked with sleep – understanding how could bring us closer to finding a cure

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.